Skip to main content

Breadcrumb

  1. Home

Full Year 2014

Developmental Screening in the First Three Years of Life

  • The percentage of children ages one, two and three years who had a developmental screening performed.

    Three rates are reported:
    Rate 1: Developmental Screening by the Child’s First Birthday
    Rate 2: Developmental Screening by the Child’s Second Birthday
    Rate 3: Developmental Screening by the Child’s Third Birthday

    CBE ID
    1399

Developmental screening using a parent completed screening tool (Parent report, Children 0-5)

  • The measure assesses whether the parent or caregiver completed a developmental screening tool meant to identify children at-risk for developmental, behavioral and social delays. Developmental screening is defined as a standardized tool that assesses the child’s risk for developmental, behavioral and social delays. The American Academy of Pediatrics recommends standardized screening using an approved screening tool as the best method of identifying children at risk for developmental, behavioral and/or social delays.

    CBE ID
    1385

Dyslipidemia new med 12-week lipid test

  • This measure identifies patients age 18 or older who started lipid-lowering medication during the measurement year and had a lipid panel checked within 3 months after starting drug therapy.

    CBE ID
    0583

ETG Based PNEUMONIA cost of care measure

  • The measure focuses on resources used to deliver episodes of care for patients with pneumonia. Pneumonia episodes are defined using the Episode Treatment Groups (ETG) methodology and describe the unique presence of the condition for a patient and the services involved in diagnosing, managing and treating pneumonia. A number of resource use measures are defined for pneumonia episodes, including overall cost of care, cost of care by type of service, and the utilization of specific types of services.

    CBE ID
    1611